freeze-dried PCR
Biofortuna Closes $2.2M Funding Round
The new investment will support an expanding contract business as well as in-house MDx development.
Biofortuna will design, develop, and manufacture a range of freeze-dried HLA-typing kits with the brand name SSPGo for Abbott's molecular diagnostics business.
The UK-based company said that its new product is the first-ever complete freeze-dried PCR kit, and can be transported and stored at ambient temperatures and used by relatively unskilled technicians, making it suitable for applications on a "global scale."